Clinical Trial Detail

NCT ID NCT01612351
Title Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Carboplatin + Cisplatin + Lapatinib + Paclitaxel

Carboplatin + Lapatinib + Paclitaxel

Age Groups: adult

No variant requirements are available.